Making Informed Decisions Earlier in Oral Drug Product Development
Early oral drug development requires teams to make consequential decisions with incomplete information. API may be scarce, timelines are compressed, and formulation and process knowledge are still developing. Yet decisions made during this period can influence clinical formulation, material requirements, manufacturing strategy, and ultimately the path a program takes through development.
In this article from Thermo Fisher Scientific, learn how predictive insights can help development teams focus experimental work, conserve limited API and identify formulation risks before they become more difficult to address.
Learn more →